efavirenz has been researched along with Hepatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chhneang, V; Fernandez, M; Laureillard, D; Moeung, S; Ngeth, C; Piketty, C; Prak, N; Quillet, C; Riel, V; Song, S | 1 |
| Gerber, JG; Wyles, DL | 1 |
| Leung, JM; O'Brien, JG; Winslow, DL; Wong, HK | 1 |
1 review(s) available for efavirenz and Hepatitis
| Article | Year |
|---|---|
Efavirenz-induced hypersensitivity reaction manifesting in rash and hepatitis in a Latino male.
Topics: Adult; Alkynes; Benzoxazines; Cyclopropanes; Drug Hypersensitivity; Exanthema; Hepatitis; Hispanic or Latino; Humans; Male | 2008 |
2 other study(ies) available for efavirenz and Hepatitis
| Article | Year |
|---|---|
Efavirenz replacement by immediate full-dose nevirapine is safe in HIV-1-infected patients in Cambodia.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cambodia; Cyclopropanes; Exanthema; Female; Hepatitis; HIV Infections; HIV-1; Humans; Male; Middle Aged; Nevirapine; Retrospective Studies; Stevens-Johnson Syndrome; Young Adult | 2008 |
Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.
Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Hepatitis; HIV Infections; Humans; Indinavir; Liver Function Tests; Lopinavir; Nelfinavir; Nevirapine; Oxazines; Protease Inhibitors; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Zidovudine | 2005 |